S14 Ep17: Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC
In this podcast, experts Aditya Bardia, MD, MPH, FASCO, Erika P. Hamilton, MD, and Virginia Kaklamani, MD, DSc, discuss frequently asked questions regarding the use of antibody-drug conjugates (ADCs) in triple-negative breast cancer (TNBC).
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.